Diabetes and Endocrinology
Home Diabetes and Endocrinology
Patisiran, Inotersen Aid Hereditary Transthyretin Amyloidosis
Improvement in modified Neuropathy Impairment Score+7, Norfolk QoL Diabetic Nephropathy score
Oral Insulin Choline, Geranate Ionic Liquid Shows Promise
Significant, sustained decrease in blood glucose levels with low insulin doses of 3 to 10 U/kg
AMA Adopts Policy to Cut Sugar Sweetened Drink Consumption
Policy supports evidence-based strategies such as excise taxes, adding warning labels
CVD Risk Up With Hypertensive Disorders of Pregnancy
Rates of chronic HTN, T2DM, hypercholesterolemia higher for women with HDP in first pregnancy
Working >45 Hours Tied to Higher Diabetes Risk in Women
Increased risk seen for women but not men; slightly attenuated after adjustment for mediating factors
June 2018 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for June 2018. This roundup includes...
Intensive Management Program Benefits High-Risk Patients
Access to intensive management program results in more outpatient care with no increase in total costs
FDA Expands Approval of Closed-Looped Insulin Delivery System
MiniMed 670G automated insulin delivery system deemed safe for children 7 to 13 with type 1 diabetes
American Diabetes Association, June 22-26
The American Diabetes Association's 78th Scientific Sessions The annual meeting of the American Diabetes Association (ADA) was held from June 22 to 26...
Prolonged Leisure-Time Sitting Tied to Increased Mortality Risk
Increase in all-cause, cardiovascular disease, cancer, diabetes, kidney disease, suicide, COPD mortality
